Aquestive Therapeutics (AQST) Equity Ratio (2017 - 2025)
Historic Equity Ratio for Aquestive Therapeutics (AQST) over the last 9 years, with Q3 2025 value amounting to 0.03.
- Aquestive Therapeutics' Equity Ratio rose 9391.81% to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03, marking a year-over-year increase of 9391.81%. This contributed to the annual value of 0.59 for FY2024, which is 6801.92% up from last year.
- Per Aquestive Therapeutics' latest filing, its Equity Ratio stood at 0.03 for Q3 2025, which was up 9391.81% from 0.77 recorded in Q2 2025.
- In the past 5 years, Aquestive Therapeutics' Equity Ratio ranged from a high of 0.03 in Q3 2025 and a low of 2.08 during Q3 2022
- In the last 5 years, Aquestive Therapeutics' Equity Ratio had a median value of 0.92 in 2021 and averaged 1.14.
- Its Equity Ratio has fluctuated over the past 5 years, first crashed by 15897.91% in 2021, then surged by 9391.81% in 2025.
- Over the past 5 years, Aquestive Therapeutics' Equity Ratio (Quarter) stood at 1.32 in 2021, then plummeted by 56.79% to 2.08 in 2022, then grew by 10.72% to 1.85 in 2023, then soared by 68.02% to 0.59 in 2024, then skyrocketed by 95.76% to 0.03 in 2025.
- Its last three reported values are 0.03 in Q3 2025, 0.77 for Q2 2025, and 0.6 during Q1 2025.